Cognition Therapeutics Files 8-K
Ticker: CGTX · Form: 8-K · Filed: Aug 26, 2025 · CIK: 1455365
| Field | Detail |
|---|---|
| Company | Cognition Therapeutics INC (CGTX) |
| Form Type | 8-K |
| Filed Date | Aug 26, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001, $1.00 m, $1.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing
Related Tickers: COGT
TL;DR
COGT filed an 8-K, standard procedure, no major news yet.
AI Summary
Cognition Therapeutics, Inc. filed an 8-K on August 26, 2025, reporting an event under "Other Events." The filing does not contain specific details about the event itself, but it confirms the company's reporting status and basic corporate information.
Why It Matters
This filing indicates Cognition Therapeutics is fulfilling its regulatory reporting obligations, which is standard for publicly traded companies.
Risk Assessment
Risk Level: low — This is a routine filing with no new material information disclosed.
Key Numbers
- 001-40886 — SEC File Number (Identifies the company's filing history with the SEC.)
- 13-4365359 — IRS Employer Identification No. (Tax identification number for the company.)
Key Players & Entities
- Cognition Therapeutics, Inc. (company) — Registrant
- August 26, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 2500 Westchester Ave. Purchase, NY 10577 (address) — Principal executive offices
FAQ
What specific event is reported under "Other Events" in this 8-K filing?
The provided text for the 8-K filing does not specify the details of the event categorized under "Other Events."
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on August 26, 2025.
What is Cognition Therapeutics, Inc.'s state of incorporation?
Cognition Therapeutics, Inc. is incorporated in Delaware.
What is the company's principal executive office address?
The company's principal executive offices are located at 2500 Westchester Ave. Purchase, NY 10577.
What is the SEC file number for Cognition Therapeutics, Inc.?
The SEC file number for Cognition Therapeutics, Inc. is 001-40886.
Filing Stats: 480 words · 2 min read · ~2 pages · Grade level 11.5 · Accepted 2025-08-26 16:01:49
Key Financial Figures
- $0.001 — h Registered Common Stock, par value $0.001 per share CGTX The Nasdaq Stock Mar
- $1.00 m — f its common stock had closed below the $1.00 minimum required by Nasdaq Listing Rule 5
- $1.00 — Company's common stock had closed above $1.00 per share for more than ten consecutive
Filing Documents
- tm2524388d1_8k.htm (8-K) — 23KB
- 0001104659-25-083059.txt ( ) — 183KB
- cgtx-20250826.xsd (EX-101.SCH) — 3KB
- cgtx-20250826_lab.xml (EX-101.LAB) — 33KB
- cgtx-20250826_pre.xml (EX-101.PRE) — 22KB
- tm2524388d1_8k_htm.xml (XML) — 4KB
01
Item 8.01 Other Events. As previously disclosed, on September 12, 2024, Cognition Therapeutics, Inc. (the "Company") received a deficiency letter from The Nasdaq Stock Market LLC ("Nasdaq") stating that the bid price of its common stock had closed below the $1.00 minimum required by Nasdaq Listing Rule 5450(a)(1) for the prior 30 consecutive trading days (the "Minimum Bid Price Requirement"). As of August 25, 2025, the Company's common stock had closed above $1.00 per share for more than ten consecutive trading days. As a result, on August 26, 2025, the Company received a letter from Nasdaq advising that the Company had regained compliance with the Minimum Bid Price Requirement and that the Company was therefore in compliance with Nasdaq's listing requirements.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. COGNITION THERAPEUTICS, INC. Date: August 26, 2025 By: /s/ Lisa Ricciardi Name: Lisa Ricciardi Title: President and Chief Executive Officer